2023年动脉瘤性蛛网膜下腔出血患者管理指南:来自美国心脏协会/美国卒中协会的指南
该指南替代2012版动脉瘤性蛛网膜下腔出血管理指南,旨在为临床医生提供以患者为中心的预防、诊断和管理推荐。写作组于2022年3月至6月系统检索MEDLINE、PubMed、Cochrane图书馆等数据库,并纳入2022年7月至11月间影响推荐内容的新研究。指南基于当前证据更新了既往多条推荐,并在有数据支持时新增推荐,以改善医疗质量并契合患者及其家庭和照护者的利益。
要点
- 本指南替代2012版动脉瘤性蛛网膜下腔出血管理指南,提供以患者为中心的推荐。
- 指南基于2022年3月至6月系统检索及2022年7月至11月补充文献制定。
- 既往多条推荐已根据新证据更新,并在有数据支持时新增推荐。
核心结论
- 指南基于当前证据提供动脉瘤性蛛网膜下腔出血预防、诊断和管理的推荐,旨在改善医疗质量并契合患者及其家庭和照护者的利益。
研究设计与样本
- 由美国心脏协会/美国卒中协会指南写作组制定,系统检索2012年指南以来以人类研究为主、英文发表并索引于MEDLINE、PubMed、Cochrane图书馆等数据库的文献。
- 检索时间为2022年3月至2022年6月,并补充纳入2022年7月至2022年11月间影响推荐内容、推荐等级或证据水平的新研究。
主要发现
- 动脉瘤性蛛网膜下腔出血是全球重大公共卫生威胁,是一种严重致残且常致命的疾病。
- 既往指南的多条推荐已根据新证据更新,并在有发表数据支持时新增推荐。
临床怎么用
- 原文未据此给出具体推荐条款。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The "2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage" replaces the 2012 "Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage." The 2023 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with aneurysmal subarachnoid hemorrhage. METHODS: A comprehensive search for literature published since the 2012 guideline, derived from research principally involving human subjects, published in English, and indexed in MEDLINE, PubMed, Cochrane Library, and other selected databases relevant to this guideline, was conducted between March 2022 and June 2022. In addition, the guideline writing group reviewed documents on related subject matter previously published by the American Heart Association. Newer studies published between July 2022 and November 2022 that affected recommendation content, Class of Recommendation, or Level of Evidence were included if appropriate. Structure: Aneurysmal subarachnoid hemorrhage is a significant global public health threat and a severely morbid and often deadly condition. The 2023 aneurysmal subarachnoid hemorrhage guideline provides recommendations based on current evidence for the treatment of these patients. The recommendations present an evidence-based approach to preventing, diagnosing, and managing patients with aneurysmal subarachnoid hemorrhage, with the intent to improve quality of care and align with patients' and their families' and caregivers' interests. Many recommendations from the previous aneurysmal subarachnoid hemorrhage guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.
引用
- Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2023. PMID: 37212182. doi:10.1161/STR.0000000000000436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。